{
  "nctId": "NCT04939792",
  "briefTitle": "Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans",
  "officialTitle": "Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans",
  "protocolDocument": {
    "nctId": "NCT04939792",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2020-11-06",
    "uploadDate": "2021-06-08T16:56",
    "size": 258935,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04939792/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "EARLY_PHASE1"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "QUADRUPLE",
  "enrollmentInfo": {
    "enrollmentCount": 165,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2020-11-06",
    "completionDate": "2022-10-31",
    "primaryCompletionDate": "2022-10-31",
    "firstSubmitDate": "2021-06-08",
    "firstPostDate": "2021-06-25"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* African American volunteers only\n* Participants between the ages of 18 and 65\n* Must be In good general health\n* Women with negative pregnancy tests\n\nExclusion Criteria:\n\n* Subjects with Diabetes, Heart disease, Sickle Cell disease, or Epilepsy\n* Subjects with serum positive pregnancy test or breastfeeding",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "65 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "25-hydroxy-vitamin D",
        "description": "Change in blood levels of 25(OH)VD",
        "timeFrame": "6 months"
      }
    ],
    "secondary": [
      {
        "measure": "TNF-Î±",
        "description": "Whether any increase in vitamin D beneficially decreases insulin resistance",
        "timeFrame": "6 months"
      },
      {
        "measure": "HOMA-IR",
        "description": "Whether any decrease in TNF-a beneficially decreases insulin resistance",
        "timeFrame": "6 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "EARLY_PHASE1"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:40.223Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}